# LanssonPharm

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lanssonpharm

- Industry: Biotechnology
- Headquarters: Guangzhou, China
- Website: www.lanssonpharm.com
- Latest round: Series A (Jan 28, 2019)
- Investors on record: 3

## About

Established in 2018 and based in Guangzhou, China, LanssonPharm operates as a biomedical developer that focuses on neuropsychic diseases.

## Funding rounds

- Series A, Jan 28, 2019 — NLVC, Qianrong Capital, Kington Capital

## Investors

- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A
- Qianrong Capital (https://capitalatlas.ai/funds/qianrong-capital) — Series A
- Kington Capital (https://capitalatlas.ai/funds/kington-capital) — Series A